Kalaris Therapeutics (KLRS) Short-term Investments (2019 - 2026)
Kalaris Therapeutics (KLRS) recorded Short-term Investments of $50.37 million in Q2 2026, down 19.8% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Short-term Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics reported Short-term Investments of $19.93 million.
- Annual Short-term Investments has a five-year compound annual growth rate of -38.9% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $93.82 million in FY2023 (-26.5%), $127.7 million in FY2022 (+174.9%) and $46.46 million in FY2021 (-80.1%).
- Quarterly Short-term Investments has ranged from $5 million in Q3 2024 to $140.27 million in Q3 2022 over the past five years.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 592.9% in Q3 2025, against a decline of 95.8% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $62.79 million (Q1 2026), $19.93 million (Q4 2025) and $34.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Kalaris Therapeutics | 47.36 Mn | -46.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.37 Mn |
| Mar 31, 2026 | 62.79 Mn |
| Dec 31, 2025 | 19.93 Mn |
| Sep 30, 2025 | 34.61 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 24.87 Mn |
| Mar 31, 2024 | 54.49 Mn |
| Dec 31, 2023 | 93.82 Mn |
| Sep 30, 2023 | 117.69 Mn |
| Jun 30, 2023 | 49.58 Mn |
| Mar 31, 2023 | 86.87 Mn |
| Dec 31, 2022 | 127.70 Mn |
| Sep 30, 2022 | 140.27 Mn |
| Jun 30, 2022 | 101.58 Mn |
| Mar 31, 2022 | 101.17 Mn |
| Dec 31, 2021 | 46.46 Mn |
| Sep 30, 2021 | 32.65 Mn |
| Jun 30, 2021 | 87.89 Mn |
| Mar 31, 2021 | 168.35 Mn |
| Dec 31, 2020 | 233.66 Mn |
API Access
Kalaris Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();